MIM
SLS icon

MetLife Investment Management’s SELLAS Life Sciences SLS Stock Holding History

MetLife Investment Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
110,082
+15,827
+17% +$109K 0.01% 1272
2026
Q1 		$399K Buy
94,255
+67,074
+247% +$300K ﹤0.01% 1861
2025
Q4 		$102K Sell
27,181
-12,792
-32% -$24.9K ﹤0.01% 2590
2025
Q3 		$64.4K Sell
39,973
-18,871
-32% -$33.6K ﹤0.01% 2772
2025
Q2 		$129K Buy
+58,844
New +$90.3K ﹤0.01% 2408

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MetLife Investment Management's SLS Position: Q2 2026 in Review

MetLife Investment Management increased its SELLAS Life Sciences (SLS) stake by 17% in Q2 2026, buying an estimated $109K and bringing the position to 110,082 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #1272.

MetLife Investment Management first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • MetLife Investment Management held 110,082 shares of SELLAS Life Sciences worth $1.62M as of Q2 2026.
  • MetLife Investment Management bought 15,827 SELLAS Life Sciences shares in Q2 2026, an estimated $109K.
  • SELLAS Life Sciences made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1272 holding.
  • MetLife Investment Management first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.